Supernus Pharmaceuticals, Inc. (SUPN) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
22/25
Growth 5
Margin 5
Expansion 4
Platform 3
Financial 5
latest quarter score
Earnings Reports
- 22
- 17
- 12
- 14
- 17
- 15